Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib was the first cancer drug simultaneously approved for two different indications.
The report details the trend, potential and market size of Sunitinib Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Sunitinib Drugmarket, defines the market attractiveness level of Sunitinib Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Sunitinib Drug industry, describes the types of Sunitinib Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Sunitinib Drug market and the development prospects and opportunities of Sunitinib Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Sunitinib Drug market in Chapter 13.
By Player:
Company 1
Company 2
Company 3
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
By Type:
25 mg Capsules
50 mg Capsules
By End-User:
Kidney cancer
GIST
pNET
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Sunitinib Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Sunitinib Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Sunitinib Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Sunitinib Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Sunitinib Drug Market Analysis and Outlook to 2022
-
7.1 Global Sunitinib Drug Consumption (2017-2022)
-
7.2 United States Sunitinib Drug Consumption (2017-2022)
-
7.3 Europe Sunitinib Drug Consumption (2017-2022)
-
7.4 China Sunitinib Drug Consumption (2017-2022)
-
7.5 Japan Sunitinib Drug Consumption (2017-2022)
-
7.6 India Sunitinib Drug Consumption (2017-2022)
-
7.7 South Korea Sunitinib Drug Consumption (2017-2022)
8 Region and Country-wise Sunitinib Drug Market Analysis and Outlook to 2028
-
8.1 Global Sunitinib Drug Consumption Forecast (2022-2028)
-
8.2 United States Sunitinib Drug Consumption Forecast (2022-2028)
-
8.3 Europe Sunitinib Drug Consumption Forecast (2022-2028)
-
8.4 China Sunitinib Drug Consumption Forecast (2022-2028)
-
8.5 Japan Sunitinib Drug Consumption Forecast (2022-2028)
-
8.6 India Sunitinib Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Sunitinib Drug Consumption Forecast (2022-2028)
9 Global Sunitinib Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Sunitinib Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 25 mg Capsules Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 50 mg Capsules Consumption and Growth Rate (2017-2022)
-
9.2 Global Sunitinib Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Kidney cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global GIST Consumption and Growth Rate (2017-2022)
-
9.2.3 Global pNET Consumption and Growth Rate (2017-2022)
10 Global Sunitinib Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Sunitinib Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 25 mg Capsules Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 50 mg Capsules Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Sunitinib Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Kidney cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global GIST Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global pNET Consumption Forecast and Growth Rate (2022-2028)
11 Global Sunitinib Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Sunitinib Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Sunitinib Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Sunitinib Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Sunitinib Drug Market Competitive Analysis
-
14.1 Company 1
-
14.1.1 Company 1 Company Details
-
14.1.2 Company 1 Sunitinib Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Company 1 Sunitinib Drug Product and Service
-
14.2 Company 2
-
14.2.1 Company 2 Company Details
-
14.2.2 Company 2 Sunitinib Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Company 2 Sunitinib Drug Product and Service
-
14.3 Company 3
-
14.3.1 Company 3 Company Details
-
14.3.2 Company 3 Sunitinib Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Company 3 Sunitinib Drug Product and Service
-
14.4 Company 4
-
14.4.1 Company 4 Company Details
-
14.4.2 Company 4 Sunitinib Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Company 4 Sunitinib Drug Product and Service
-
14.5 Company 5
-
14.5.1 Company 5 Company Details
-
14.5.2 Company 5 Sunitinib Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Company 5 Sunitinib Drug Product and Service
-
14.6 Company 6
-
14.6.1 Company 6 Company Details
-
14.6.2 Company 6 Sunitinib Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Company 6 Sunitinib Drug Product and Service
-
14.7 Company 7
-
14.7.1 Company 7 Company Details
-
14.7.2 Company 7 Sunitinib Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Company 7 Sunitinib Drug Product and Service
-
14.8 Company 8
-
14.8.1 Company 8 Company Details
-
14.8.2 Company 8 Sunitinib Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Company 8 Sunitinib Drug Product and Service
-
14.9 Company 9
-
14.9.1 Company 9 Company Details
-
14.9.2 Company 9 Sunitinib Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Company 9 Sunitinib Drug Product and Service
-
14.10 Company 10
-
14.10.1 Company 10 Company Details
-
14.10.2 Company 10 Sunitinib Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Company 10 Sunitinib Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Sunitinib Drug
-
Figure Sunitinib Drug Picture
-
Table Global Sunitinib Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Sunitinib Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Sunitinib Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Sunitinib Drug Consumption by Country (2017-2022)
-
Figure United States Sunitinib Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Sunitinib Drug Consumption and Growth Rate (2017-2022)
-
Figure China Sunitinib Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Sunitinib Drug Consumption and Growth Rate (2017-2022)
-
Figure India Sunitinib Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Sunitinib Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Sunitinib Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Sunitinib Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Sunitinib Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Sunitinib Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Sunitinib Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Sunitinib Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Sunitinib Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 25 mg Capsules Consumption and Growth Rate (2017-2022)
-
Figure Global 50 mg Capsules Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney cancer Consumption and Growth Rate (2017-2022)
-
Figure Global GIST Consumption and Growth Rate (2017-2022)
-
Figure Global pNET Consumption and Growth Rate (2017-2022)
-
Figure Global 25 mg Capsules Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 50 mg Capsules Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kidney cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GIST Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global pNET Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Sunitinib Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Sunitinib Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Company 1 (Foundation Year, Company Profile and etc.)
-
Table Company 1 Sunitinib Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 1 Sunitinib Drug Product and Service
-
Table Company 2 (Foundation Year, Company Profile and etc.)
-
Table Company 2 Sunitinib Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 2 Sunitinib Drug Product and Service
-
Table Company 3 (Foundation Year, Company Profile and etc.)
-
Table Company 3 Sunitinib Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 3 Sunitinib Drug Product and Service
-
Table Company 4 (Foundation Year, Company Profile and etc.)
-
Table Company 4 Sunitinib Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 4 Sunitinib Drug Product and Service
-
Table Company 5 (Foundation Year, Company Profile and etc.)
-
Table Company 5 Sunitinib Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 5 Sunitinib Drug Product and Service
-
Table Company 6 (Foundation Year, Company Profile and etc.)
-
Table Company 6 Sunitinib Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 6 Sunitinib Drug Product and Service
-
Table Company 7 (Foundation Year, Company Profile and etc.)
-
Table Company 7 Sunitinib Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 7 Sunitinib Drug Product and Service
-
Table Company 8 (Foundation Year, Company Profile and etc.)
-
Table Company 8 Sunitinib Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 8 Sunitinib Drug Product and Service
-
Table Company 9 (Foundation Year, Company Profile and etc.)
-
Table Company 9 Sunitinib Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 9 Sunitinib Drug Product and Service
-
Table Company 10 (Foundation Year, Company Profile and etc.)
-
Table Company 10 Sunitinib Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 10 Sunitinib Drug Product and Service
-
